Advances in new psychoactive substances identification: the U.R.I.To.N. Consortium

References

• European Drug Report 2016: Trends and Developments. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Available from: http://www.emcdda.europa.eu/system/files/publications/2637/TDAT16001ENN.pdf [last accessed 27 Apr 2017].
   Google Scholar
• (a) Valter K, Arrizabalaga P. Designer drugs directory. Amsterdam: Elsiever; 1998.
   Google Scholar
  (b) Bertol E, Pascali J, Palumbo D, et al. 3-MeO-PCP intoxication in two young men: first in vivo detection in Italy. Forensic Sci Int 2017;274:7–12.
   PubMed Web of Science ®Google Scholar
• European Drug Report 2015: Trends and Developments. European Monitoring Centre for Drugs and drug Addiction (EMCDDA). Available from: http://www.emcdda.europa.eu/system/files/publications/974/TDAT15001ENN.pdf [last accessed 27 Apr 2017].
   Google Scholar
• https://www.unodc.org/unodc/en/commissions/CND/conventions.html [last accessed 27 Jan 2017].
   Google Scholar
• https://www.unodc.org/LSS/Page/NPS/Resources [last accessed 27 Apr 2017].
   Google Scholar
• (a) Andrade AF, Mamo SK, Gonzalez-Rodriguez J. Rapid screening method for new psychoactive substances of forensic interest: electrochemistry and analytical determination of phenethylamines derivatives (NBOMe) via cyclic and differential pulse voltammetry. Anal Chem 2017;89:1445–52.
   PubMed Web of Science ®Google Scholar
  (b) Mollerup CB, Dalsgaard PW, Mardal M, Linnet K. Targeted and non-targeted drug screening in whole blood by UHPLC-TOF-MS with data-independent acquisition. Drug Test Anal 2016. [Epub ahead of print]. doi: 10.1002/dta.2120
   PubMed Web of Science ®Google Scholar
  (c) Borg D, Tverdovsky A, Stripp R. A fast and comprehensive analysis of 32 synthetic cannabinoids using Agilent triple quadrupole LC–MS-MS. J Anal Toxicol 2017;41:6–16.
   PubMed Web of Science ®Google Scholar
  (d) Vaiano F, Busardò FP, Palumbo D, et al. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC–MS/MS and application to real cases. J Pharm Biomed Anal 2016;129:441–9.
   PubMed Web of Science ®Google Scholar
  (e) Smith JP, Sutcliffe OB, Banks CE. An overview of recent developments in the analytical detection of new psychoactive substances (NPSs). Analyst 2015;140:4932–48.
   PubMed Web of Science ®Google Scholar
• SWGDRUG Recommendations (edition 7.0, 2014). Available from: http://www.swgdrug.org/Documents/SWGDRUG%20-Recommendations%20Version%207-0_Archived.pdf [last accessed 27 Apr 2017].
   Google Scholar
• (a) Bertol E, Mari F, Boscolo Berto R, et al. A mixed MDPV and benzodiazepine intoxication in a chronic drug abuser: determination of MDPV metabolites by LC–HRMS and discussion of the case. Forensic Sci Int 2014;243:149–55.
   PubMed Web of Science ®Google Scholar
  (b) Bertol E, Vaiano F, Di Milia MG, Mari F. In vivo detection of the new psychoactive substance AM-694 and its metabolites. Forensic Sci Int 2015;256:21–7.
   PubMed Web of Science ®Google Scholar
• Frison G, Odoardi S, Frasson S, et al. Characterization of the designer drug bk-2C-B (2-amino-1-(bromo-dimethoxyphenyl)ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance. Rapid Commun Mass Spectrom 2015;29:1196–204.
   PubMed Web of Science ®Google Scholar
• Welter J, Kavanagh P, Meyer RM, Maurer HH. Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC–MS and LC-(HR)-MS(n) techniques. Anal Bioanal Chem 2015;407:1371–88.
   PubMed Web of Science ®Google Scholar
• Sahai MA, Davidson C, Khelashvili G, et al. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances – the case of the benzofuran 5-MAPB. Prog Neuropsychopharmacol Biol Psychiatry 2017;75:1–9.
   Web of Science ®Google Scholar
• (a) Nakagawa Y, Suzuki T, Tada Y, Inomata A. Cytotoxic effects of psychotropic benzofuran derivatives, N-methyl-5-(2-aminopropyl)benzofuran and its N-demethylated derivative, on isolated rat hepatocytes. J Appl Toxicol 2017;37:243–52.
   PubMed Web of Science ®Google Scholar
  (b) Shimshoni JA, Winkler I, Golan E, Nutt D. Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. Naunyn Schmiedebergs Arch Pharmacol 2017;390:15–24.
   PubMed Web of Science ®Google Scholar
• Hofer KE, Faber K, Müller DM, et al. Acute toxicity associated with the recreational use of the novel psychoactive benzofuran N-methyl-5-(2 aminopropyl)benzofuran. Ann Emerg Med 2017;69:79–82.
   PubMed Web of Science ®Google Scholar
• Iversen L, Gibbons S, Treble R, et al. Neurochemical profiles of some novel psychoactive substances. Eur J Pharmacol 2013;700:147–51.
   PubMed Web of Science ®Google Scholar
• (a) Shulgin AT, Carter MF. Centrally active phenethylamines. Psychopharmacol Commun 1975;1:93–8.
   Google Scholar
  (b) Shulgin AT, Manning T, Daley PF. The Shulgin index. Psychedelic phenethylamines and related compounds. Vol. 1. Berkeley, CA: Transform Press; 2011.
   Google Scholar
• (a) Bluelight. The Big & Dandy βK-2C-B Thread – Part 1. Available from: http://www.bluelight.org/vb/threads/694585-The-Big-amp-Dandy-K-2C-B-Thread-Part-1 [last accessed 27Apr 2017].
   Google Scholar
  (b) reddit. bk-2C-B. Available from: https://www.reddit.com/r/Drugs/comments/1qbne0/bk2cb/
   Google Scholar
• Hill SL, Thomas SH. Clinical toxicology of newer recreational drugs. Clin Toxicol (Phila) 2011;49:705–19.
   PubMed Web of Science ®Google Scholar
• (a) Arunotayanun W, Dalley JW, Huang XP, et al. An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging ‘Novel Psychoactive Drugs’. Bioorg Med Chem Lett 2013;23:3411–5.
   PubMed Web of Science ®Google Scholar
  (b) Nagai F, Nonaka R, Satoh Hisashi Kamimura K. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 2007;559:132–7.
   PubMed Web of Science ®Google Scholar
• (a) Shulgin A, Shulgin A. Book II of TiHKAL: the continuation. Berkeley, CA: Transform Press; 1997.
   Google Scholar
  (b) Long H, Nelson LS, Hoffman RS. Alpha-methyltryptamine revisited via easy Internet access. Vet Hum Toxicol 2003;45:149.
   PubMedGoogle Scholar
• (a) Elliott SP, Brandt SD, Freeman S, Archer RP. AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis. Drug Test Anal 2013;5:196–202.
   PubMed Web of Science ®Google Scholar
  (b) Boland DM, Andollo W, Hime GW, Hearn WL. Fatality due to acute alpha-methyltryptamine intoxication. J Anal Toxicol 2005;29:394–7.
   PubMed Web of Science ®Google Scholar
• https://chemspider.com, https://pubchem.ncbi.nlm.nih.gov/ [last accessed 27 Apr 2017].
   Google Scholar
• Karplus M. Vicinal proton coupling in nuclear magnetic resonance. J Am Chem Soc 1963;85:2870–1.
   Web of Science ®Google Scholar
• Robaa D, Enzensperger C, Eldin Abulazm S, et al. Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives. J Med Chem 2011;54:7422–6.
   PubMed Web of Science ®Google Scholar